Solutions for Drug-Resistant Infections Conference, Brisbane Australia April 3-5, 2017

Author: Richard Taylor

Ar2wfau 400x400

SDRI 2017 is a multi-disciplinary scientific conference focused on Solutions for Drug Resistant Infections. This inaugural conference theme is New Drugs for Drug-Resistant Infections. The conference will take place at the Brisbane Convention and Exhibition Centre in Australia from 3 – 5 April, 2017.

The program is expected to attract 400 international participants and will provide a fantastic forum for researchers and industry representatives working in the space of microbiology, virology, parasitology, genomics, pharmacology and medicinal chemistry, to network and discuss new ways to solve the global challenge of drug-resistant infections. Our goal for SDRI 2017 is to lead a concerted discussion to set three priorities and guide research efforts towards global solutions for drug resistance research.

 

Conference sessions:
•     Antimicrobial resistance
•     Antimicrobial drug discovery
•     Improvements to existing anti-infective agents and repurposing
•     New Drug Targets
•     Alternate therapies
•     Navigating the pipeline
•     International Models and Funding
•     Vector control and vaccines

Plenary Speakers:
•    Professor Dame Sally Davies, Chief Medical Officer for England
•    Professor Ramanan Laxminarayan, Vice President, Research and Policy (Public Health Foundation of India (PHFI) and Director Center for Disease Dynamics, Economics & Policy (CDDEP) Washington DC

Invited Speakers:

•     Dr Manica Balasegaram, Director, Global Antibiotic R&D Partnership, DNDi
•     Associate Professor Heidi Drummer, Burnet Instiute, Australia
•     Professor Bob Hancock, University of British Columbia
•     Dr Timothy Jinks, Strategy Development Lead, Wellcome Trust
•     Dr Jennifer Leeds, Executive Director – Antibacterial Discovery, Infectious Diseases Area, Novartis Institutes for BioMedical Research, California, USA
•     Dr Line Matthiessen, Health European Commission – DG Research & Innovation
•     Dr Terry Roemer, Head of Antimicrobial Discovery, Merck
•     Dr David Shlaes, Anti-infectives Consultant
•     Dr Man-Wah Tan, Director and Senior Scientist, Infectious Diseases, Genentech, California, USA
•     Professor Elizabeth Winzeler, University of California
•     Professor Gerry Wright, Director of the Michael G. DeGroote Institute for Infectious Disease Research, Ontaria, Canada
•     Dr Zuoyu Xu, National Institute of Allergy and Infectious Diseases

Key dates:

•     Oral and poster abstract deadline: 14 October 2016
•     Earlybird deadline: 9 December 2016
•     Conference: 3 – 5 April, 2017

Originally published by Richard Taylor at drugdiscovery.nd.edu on August 30, 2016.